Peter Ordentlich

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Method of treating cancer using a combination of entinostat and an...
- Patent number 12,168,054
- Issue date Dec 17, 2024
- SYNDAX PHARMACEUTICALS, INC.
- Peter Ordentlich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selection of patients for combination therapy
- Patent number 12,000,829
- Issue date Jun 4, 2024
- SYNDAX PHARMACEUTICALS, INC.
- Peter Ordentlich
- G01 - MEASURING TESTING
Information Patent Grant
Selection of patients for combination therapy
- Patent number 11,397,184
- Issue date Jul 26, 2022
- SYNDAX PHARMACEUTICALS, INC.
- Peter Ordentlich
- G01 - MEASURING TESTING
Information Patent Grant
Combination of HDAC inhibitor and anti-PD-1 antibody for treatment...
- Patent number 11,324,822
- Issue date May 10, 2022
- SYNDAX PHARMACEUTICALS, INC.
- Robert Goodenow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the treatment of breast cancer
- Patent number 10,226,472
- Issue date Mar 12, 2019
- SYNDAX PHARMACEUTICALS, INC.
- Robert Goodenow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrimidine compositions and methods of use
- Patent number 8,455,489
- Issue date Jun 4, 2013
- Exelixis, Inc.
- Richard Martin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
SMRT co-repressors, transcriptional co-repressors that interact wit...
- Patent number 7,314,747
- Issue date Jan 1, 2008
- The Salk Institute for Biological Studies
- Ronald M. Evans
- G01 - MEASURING TESTING
Information Patent Grant
Histone deacetylase, and uses therefor
- Patent number 6,673,587
- Issue date Jan 6, 2004
- The Salk Institute for Biological Studies
- Ronald M. Evans
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT...
- Publication number 20240398944
- Publication date Dec 5, 2024
- SYNDAX PHARMACEUTICALS, INC.
- Robert GOODENOW
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTION OF PATIENTS FOR COMBINATION THERAPY
- Publication number 20240288425
- Publication date Aug 29, 2024
- SYNDAX PHARMACEUTICALS, INC.
- Peter ORDENTLICH
- G01 - MEASURING TESTING
Information Patent Application
COMBINATIONS FOR TREATMENT OF CANCER
- Publication number 20240238291
- Publication date Jul 18, 2024
- SYNDAX PHARMACEUTICALS, INC.
- Gerald M. MCGEEHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATIONS OF MENIN INHIBITORS AND CYP3A4 INHIBITORS AND METHODS...
- Publication number 20230165858
- Publication date Jun 1, 2023
- SYNDAX PHARMACEUTICALS, INC.
- Gerard M. MCGEEHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTION OF PATIENTS FOR COMBINATION THERAPY
- Publication number 20230061048
- Publication date Mar 2, 2023
- SYNDAX PHARMACEUTICALS, INC.
- Peter Ordentlich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES FOR THE TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE
- Publication number 20230035183
- Publication date Feb 2, 2023
- SYNDAX PHARMACEUTICALS, INC.
- Peter ORDENTLICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT...
- Publication number 20230022573
- Publication date Jan 26, 2023
- SYNDAX PHARMACEUTICALS, INC.
- Robert GOODENOW
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTION OF PATIENTS FOR COMBINATION THERAPY
- Publication number 20210239697
- Publication date Aug 5, 2021
- SYNDAX PHARMACEUTICALS, INC.
- Peter ORDENTLICH
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION THERAPIES
- Publication number 20200171150
- Publication date Jun 4, 2020
- SYNDAX PHARMACEUTICALS, INC.
- Peter ORDENTLICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR THE TREATMENT OF BREAST CANCER
- Publication number 20190343844
- Publication date Nov 14, 2019
- SYNDAX PHARMACEUTICALS, INC.
- Robert Goodenow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF HDAC INHIBITOR AND ANTI-PD-L1 ANTIBODY FOR TREATMENT...
- Publication number 20190290759
- Publication date Sep 26, 2019
- SYNDAX PHARMACEUTICALS, INC.
- Peter Ordentlich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF HDAC INHIBITOR AND ANTI-PD-L1 ANTIBODY FOR TREATMENT...
- Publication number 20180353602
- Publication date Dec 13, 2018
- SYNDAX PHARMACEUTICALS, INC.
- Robert Goodenow
- G01 - MEASURING TESTING
Information Patent Application
SELECTION OF PATIENTS FOR COMBINATION THERAPY
- Publication number 20180252721
- Publication date Sep 6, 2018
- SYNDAX PHARMACEUTICALS, INC.
- Peter Ordentlich
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT...
- Publication number 20180078639
- Publication date Mar 22, 2018
- SYNDAX PHARMACEUTICALS, INC.
- Robert GOODENOW
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR THE TREATMENT OF BREAST CANCER
- Publication number 20140378420
- Publication date Dec 25, 2014
- SYNDAX PHARMACEUTICALS, INC.
- Robert Goodenow
- G01 - MEASURING TESTING
Information Patent Application
ADMINISTRATION OF AN INHIBITOR OF HDAC
- Publication number 20130303575
- Publication date Nov 14, 2013
- SYNDAX PHARMACEUTICALS, INC.
- Konrad BURKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR THE TREATMENT OF LUNG CANCER
- Publication number 20130150386
- Publication date Jun 13, 2013
- SYNDAX PHARMACEUTICALS, INC.
- Robert Goodenow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Administration of an Inhibitor of HDAC, an Inhibitor of HER-2, and...
- Publication number 20110182888
- Publication date Jul 28, 2011
- Peter Ordentlich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Administration of an Inhibitor of HDAC
- Publication number 20100305167
- Publication date Dec 2, 2010
- SYNDAX PHARMACEUTICALS, INC.
- Konrad Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel Compounds and Methods of Using Them
- Publication number 20100298270
- Publication date Nov 25, 2010
- SYNDAX PHARMACEUTICALS, INC.
- John F.W. Keana
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Compounds and Methods of Using Them
- Publication number 20100267779
- Publication date Oct 21, 2010
- SYNDAX PHARMACEUTICALS, INC.
- John F.W. Keana
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Administration of an Inhibitor of HDAC and an mTOR Inhibitor
- Publication number 20090149511
- Publication date Jun 11, 2009
- SYNDAX PHARMACEUTICALS, INC.
- Konrad Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF ERa+ LIGANDS AND HISTONE DEACETYLASE INHIBITORS FOR...
- Publication number 20080242648
- Publication date Oct 2, 2008
- Syndax Pharmaceuticals, Inc., a California Corporation
- Peter Ordentlich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Substituted Pyrimidine Compositions and Methods of Use
- Publication number 20070293464
- Publication date Dec 20, 2007
- X-Ceptor Therapeutics, Inc.
- Richard Martin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Peter Ordentlich

Person

Patents Grantslast 30 patents

Method of treating cancer using a combination of entinostat and an...

Selection of patients for combination therapy

Selection of patients for combination therapy

Combination of HDAC inhibitor and anti-PD-1 antibody for treatment...

Methods for the treatment of breast cancer

Substituted pyrimidine compositions and methods of use

SMRT co-repressors, transcriptional co-repressors that interact wit...

Histone deacetylase, and uses therefor

Patents Applicationslast 30 patents

COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT...

SELECTION OF PATIENTS FOR COMBINATION THERAPY

COMBINATIONS FOR TREATMENT OF CANCER

COMBINATIONS OF MENIN INHIBITORS AND CYP3A4 INHIBITORS AND METHODS...

SELECTION OF PATIENTS FOR COMBINATION THERAPY

ANTIBODIES FOR THE TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE

COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT...

SELECTION OF PATIENTS FOR COMBINATION THERAPY

COMBINATION THERAPIES

METHODS FOR THE TREATMENT OF BREAST CANCER

COMBINATION OF HDAC INHIBITOR AND ANTI-PD-L1 ANTIBODY FOR TREATMENT...

COMBINATION OF HDAC INHIBITOR AND ANTI-PD-L1 ANTIBODY FOR TREATMENT...

SELECTION OF PATIENTS FOR COMBINATION THERAPY

COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT...

METHODS FOR THE TREATMENT OF BREAST CANCER

ADMINISTRATION OF AN INHIBITOR OF HDAC

METHODS FOR THE TREATMENT OF LUNG CANCER

Administration of an Inhibitor of HDAC, an Inhibitor of HER-2, and...

Administration of an Inhibitor of HDAC

Novel Compounds and Methods of Using Them

Novel Compounds and Methods of Using Them

Administration of an Inhibitor of HDAC and an mTOR Inhibitor

COMBINATION OF ERa+ LIGANDS AND HISTONE DEACETYLASE INHIBITORS FOR...

Substituted Pyrimidine Compositions and Methods of Use